vaccine licensing deal
Amplitude Therapeutics Partners With Lilly on taRNA Vaccines
Amplitude Therapeutics, a private Boston-based biotechnology company, announced on August 19 a strategic research collaboration and licensing agreement with Eli Lilly and Company (NYSE: LLY) to discover and develop vaccines using Amplitude’s trans-amplifying RNA (taRNA) platform for infectious diseases. The companies did not name the specific diseases involved, describing the initial focus only as infectious…
